Kanak Capital Markets Recognized as 'Best Online Trading Platform for Multi-Asset Brokerage' at Forex Traders Summit 2025
Selected by a panel of industry experts, the award recognizes Kanak Capital Markets strong performance in delivering versatile, high-speed trading platforms tailored to the needs of modern traders. Known for its commitment to customer-driven solutions, the company currently supports global clients through two robust platforms: MetaTrader 5 (MT5) andKanak Trader. MT5 is integrated with enhanced features, including expanded asset class coverage, smart order routing, and real-time performance tracking. Kanak Trader, the firm's proprietary platform, offers a customizable interface, integrated volatility alerts, low-latency infrastructure, and dynamic risk management tools designed for both active and high-frequency traders.
This recognition comes as Kanak Capital Markets strategically expands its global footprint and strengthening its regulatory framework. As a multi-regulated broker, the firm adheres to stringent international standards, ensuring secure, transparent, and compliant access to global financial markets.
In response to shifting market dynamics, Kanak Capital Markets is advancing its capabilities through automation, predictive analytics, and emerging trading technologies to deliver a more agile, data-driven trading environment.
The Forex Traders Summit annually brings together leading brokers, fintech innovators, and institutional investors to celebrate excellence in trading and financial services.
Media Contact:
Team Kanak Capital Markets
Phone: 80006512002
Website: www.kanakmarkets.com
SOURCE: Kanak Capital Markets
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 hours ago
- Yahoo
HOOD's July 2025 DARTs Jump: Is Product Suite Expansion Paying Off?
For July, Robinhood Markets, Inc. HOOD reported an increase in equity, options and crypto Daily Average Revenue Trades (DARTs) from the year-ago period. Equity DARTs in July were 2.7 million, surging 29% from the prior-year quarter. Further, Options DARTs rose 22% year over year to 1.1 million, while crypto DARTs soared 133% to 0.7 data reflect that Robinhood's efforts to become a leader in the active trader market have started bearing fruit. The company has been diversifying its offerings to capitalize on investor demands and expand into lucrative businesses. In this context, HOOD has launched several initiatives to attract more clients and strengthen its market share. In June, it introduced U.S. stock and exchange-traded fund (ETF) tokens for European Union ('EU') investors. Further, it introduced Crypto Staking for eligible U.S. investors, beginning with Ethereum and Solana. Other notable product launches include Robinhood Legend (desktop trading platform) aimed at retail investors seeking more advanced trading tools; Robinhood Strategies, Robinhood Banking and Robinhood Cortex to boost the wealth management offerings, the prediction markets hub and a credit card to expand in the consumer finance space. So, rapid product innovation through vertical integration will likely continue to expand Robinhood's client base, enabling an improvement in transaction-based revenues. The metric recorded a five-year compound annual growth rate (CAGR) of 36.7% (ended 2024), primarily driven by options and equities trading. The uptrend persisted in the first half of 2025. Other Details From Robinhood's July Operating Data In July 2025, HOOD's total platform assets were $298 billion, jumping 106% year over year. Further, net deposits were $6.4 billion, up 52%. Funded customers totaled 26.7 million, up 10% from July 2024. Robinhood's equity notional trading volumes were 209.1 billion in July, up 100% year over year. Option contracts traded increased 22% to 195.8 million. Robinhood App Crypto notional trading volumes were $16.8 billion, up 217% from the prior-year month, while Crypto Notional Trading Volumes were $11.9 billion. At the end of July, margin balances were $11.4 billion, which surged 111% year over year. HOOD recorded total cash sweep balances of $33.6 billion, up 54% from July 2024. Total securities lending revenues of $61 million grew 190% from the year-ago month. How Competitors are Scaling Up to Challenge Robinhood? HOOD's key competitors, Interactive Brokers IBKR and Tradeweb Markets Inc. TW, have been rolling out products to bolster their market Brokers has been continuously making efforts to develop proprietary software to automate broker-dealer functions and expand its product suite and reach of its services. Earlier this week, it launched the IBKR Lite plan in Singapore, offering investors in the country a commission-free way to trade U.S. stocks and ETFs around the clock. In recent months, Interactive Brokers has expanded trading hours for Forecast Contracts to nearly 24/5, launched a prediction markets hub in Canada and introduced Plan d'Epargne en Actions accounts in France. The IBKR GlobalTrader app now enables worldwide stock trading, and the firm was among the first to offer overnight U.S. stock and ETF trading. Under CEO Billy Hult, Tradeweb continues pushing the "electronification" of bond markets, having expanded beyond government bonds into mortgages, interest-rate swaps, ETFs and emerging markets, plus a new frontier in private credit. It is investing in blockchain and distributed ledger technology to improve settlement and collateral management. AI is another strategic focus for Tradeweb, with machine learning tools enhancing trade execution and dealer-client matching. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Interactive Brokers Group, Inc. (IBKR) : Free Stock Analysis Report Tradeweb Markets Inc. (TW) : Free Stock Analysis Report Robinhood Markets, Inc. (HOOD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
2 days ago
- Business Insider
PrimeXBT Updates Leverage on Bitcoin and Ethereum: BTC Up to 500x, ETH Up to 400x
PrimeXBT, a leading multi-asset broker, has rolled out a major update to its trading conditions on crypto majors, increasing leverage on Bitcoin (BTC) up to 500x and Ethereum (ETH) up to 400x. This update places PrimeXBT among a limited number of global brokers offering high leverage on major digital assets, while reminding clients that higher leverage also increases the potential for rapid losses. The leverage updates apply across both PXTrader and MT5 platforms and are now live for all users and supported regions. Traders may access higher leverage automatically, with no additional steps required, enabling lower margin requirements and more efficient use of capital. According to PrimeXBT, high-leverage trading remains a core demand among active crypto users. With this update, the crypto & CFD broker is addressing that need while maintaining the flexibility and execution quality PrimeXBT is known for. PrimeXBT continues to monitor margin requirements and risk parameters to help support platform stability and client protection. Following the BTC and ETH leverage update, PrimeXBT has also aligned altcoin leverage across PXTrader and MT5, with most altcoins now trading with up to 1:100 leverage, and higher position limits for more flexible trading in volatile markets. This update is part of a broader enhancement across multiple asset classes, including increased leverage on Forex pairs, unified conditions on major US indices, and adjusted commodity leverage to reflect market liquidity and volatility, reinforcing PrimeXBT's commitment to client-focused innovation and superior trading experience. As the crypto trading landscape evolves, PrimeXBT continues to empower traders worldwide with advanced tools, flexible leverage options, and optimised trading conditions designed to meet the needs of modern traders. To learn more, users can visit the PrimeXBT website. About PrimeXBT PrimeXBT is a global multi-asset broker trusted by over 1,000,000 traders in 150+ countries, offering a next-generation trading experience that bridges traditional and digital finance. Clients can trade CFDs on Stocks, Indices, Commodities and Crypto, as well as Crypto Futures and Forex. PrimeXBT also enables clients to buy and sell cryptocurrencies, store them in secure built-in wallets, and instantly exchange crypto to crypto or fiat to crypto, all within one integrated environment. Since 2018, PrimeXBT has made investing more accessible by lowering barriers to entry and providing secure, easy access to financial markets. This accessibility extends across its native web and mobile platforms, MetaTrader 5, and a variety of funding options in crypto, fiat, and local payment methods. Committed to putting clients first, PrimeXBT empowers traders of all levels with innovative tools and industry-leading conditions, delivering a better way to trade. Disclaimer: The content provided here is for informational purposes only and is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results. The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money. The Company does not accept clients from the Restricted Jurisdictions as indicated on its website / T&Cs. Some products and services, including MT5, may not be available in your jurisdiction. The applicable legal entity and its respective products and services depend on the client's country of residence and the entity with which the client has established a contractual relationship during registration.
Yahoo
2 days ago
- Yahoo
Alligator Bioscience to Host Virtual R&D Day on 19 August 2025
LUND, SE / / August 14, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today announces that it will host a virtual R&D Day on Tuesday, 19 August 2025 at 4 p.m. CEST. The event will provide an in-depth update on Alligator's R&D pipeline, with a primary focus on its lead candidate mitazalimab, ahead of the upcoming TO 13 warrant exercise period (1-15 September 2025). During the event, members of Alligator's executive management and R&D leadership will: Provide update on mitazalimab clinical data, as well biomarker findings and Phase 3 readiness. Discuss ongoing and planned investigator-initiated trials (IITs) exploring mitazalimab in additional indications and clinical settings. Provide a brief update on the pipeline program HLX22. Outline key R&D milestones over the next 6-12 months. The R&D Day will be held as a live Teams webinar and will include a Q&A session. All participants will have the opportunity to submit questions in advance, via ir@ or during the event. Event detailsDate: Tuesday, 19 August 2025Time: 4-5 p.m. CESTFormat: Virtual Teams webinarRegistration: Please use this link to register A replay of the event will be made available on Alligator's website after the webinar. For further information, please contact: Søren Bregenholt, CEOE-mail: +46 (0) 46 540 82 00 The information was submitted for publication, through the agency of the contact person set out above, at 1:00 p.m. CEST on 14 August 2025. About Alligator Bioscience Alligator is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. This validated approach promotes priming of tumor-specific T cells and reversing the immunosuppressive nature of the tumor microenvironment, with significant potential benefits for cancer patients across multiple types of cancer. The Company's lead drug candidate mitazalimab is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 24-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1. Alligator is listed on Nasdaq Stockholm (ATORX) and headquartered in Lund, Sweden. For more information, please visit Attachments Alligator Bioscience to host virtual R&D Day on 19 August 2025 SOURCE: Alligator Bioscience View the original press release on ACCESS Newswire Sign in to access your portfolio
